other material
confidence high
sentiment neutral
materiality 0.80
X4 Pharmaceuticals raises ~$145.6M in public offering of common stock and warrants
X4 Pharmaceuticals, Inc
- Offering of 45.86M shares at $2.90/share and pre-funded warrants for 700K shares at $2.899/share.
- Underwriters' option for additional 6.984M shares exercised in full.
- Net proceeds expected ~$145.6M after discounts and expenses; closing October 27, 2025.
- Offered under effective shelf registration (333-273961); Leerink, Stifel, Guggenheim as representatives.